Seizure emergencies involving prolonged seizures are unlikely to stop without treatment, may become more difficult to control with time, and may lead to significant morbidity and mortality. This confirmatory study (EP0162) will investigate the efficacy and safety of a s...
We've found 6 total result s for "Emergencies".
This prospective discovery study is designed to demonstrate the feasibility of using an unshielded, mobile MCG device in an Emergency Department (ED) setting. The main question it aims to answer is whether interpretable data can be reliably collected as part of an E...
Age: 18 years - 66+
Gender: All
COVID-19 can trigger a dysregulated immune response, and previous studies have shown that immune modulation can improve outcomes in hospitalized patients. This trial is designed to determine whether intensification of immune modulation early in the course of the dis...
Age: 18 years - 66+
Gender: All
Treatments are needed to improve outcomes among patients hospitalized for COVID-19, including direct-acting antiviral (DAA) agents to mitigate the pathology driven by ongoing viral replication. This trial will evaluate S-217622 (ensitrelvir), an anti-SARS-CoV2 3C-li...
Age: 18 years - 66+
Gender: All
This project, involving two distinct clinical trials, tests whether induction to a higher than currently recommended buprenorphine (BUP) induction dose is safe and can improve the proportion of patients who engage in comprehensive addiction services within 7-day of ...
Age: 18 years - 66+
Gender: All
Syncope, or transient loss of consciousness, is a common reason for visit to the Emergency Department and often leads to extensive testing and hospitalization. Using objective risk scores to determine which patients with syncope will actually benefit from these in...
Age: 40 years - 66+
Gender: All